Global Rivaroxaban Market Research Report 2016

Publisher Name :
Date: 18-Jan-2017
No. of pages: 98
Inquire Before Buying

The Global Rivaroxaban Market Research Report 2016 is a professional and in-depth study on the current state of the Rivaroxaban market. The Rivaroxaban market is expected to reach USD 2,242.0 Million by 2021 from USD 1,034.2 Million in 2015, at a CAGR of 16.7% during the forecast period.

This report focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering

Bayer

J&J

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Rivaroxaban in these regions, from 2011 to 2021 (forecast), like

North America

China

Europe

Japan

Southeast Asia

India

Split by product Types, with production, revenue, price, market share and growth rate of each type, can be divided into

2.5 mg

10 mg

15 mg

20 mg

Split by Applications, this report focuses on consumption, market share and growth rate of Rivaroxaban in each application, can be divided into

Acute coronary syndrome (ACS)

Venous thromboembolism (VTE)

Global Rivaroxaban Market Research Report 2016

Table of Contents
1 Rivaroxaban Market Overview 1
1.1 Product Overview and Scope of Rivaroxaban 1
1.2 Rivaroxaban Segment by Types 3
1.2.1 Global Production Market Share of Rivaroxaban by Types in 2015 3
1.2.2 2.5 mg 4
1.2.3 10 mg 5
1.2.4 15 mg 6
1.2.5 20 mg 8
1.3 Rivaroxaban Segment by Applications 9
1.4 Rivaroxaban Market by Regions 11
1.4.1 North America Status and Prospect (2011-2021) 11
1.4.2 China Status and Prospect (2011-2021) 12
1.4.3 Europe Status and Prospect (2011-2021) 12
1.4.4 Japan Status and Prospect (2011-2021) 13
1.4.5 Southeast Asia Status and Prospect (2011-2021) 14
1.4.6 India Status and Prospect (2011-2021) 15
1.5 Global Revenue of Rivaroxaban (2011-2021) 16
2 Global Rivaroxaban Market Competition by Manufacturers 17
2.1 Global Rivaroxaban Sales and Share by Manufacturers (2015 and 2016) 17
2.2 Global Rivaroxaban Revenue and Share by Manufacturers (2015 and 2016) 19
2.3 Global Rivaroxaban Average Price by Manufacturers (2015 and 2016) 21
2.4 Manufacturers Rivaroxaban Manufacturing Base Distribution, Sales Area, Product Types 22
2.5 Rivaroxaban Market Competitive Situation and Trends 22
3 Global Rivaroxaban Capacity, Production, Market Size (Value) by Regions (2011-2016) 25
3.1 Global Rivaroxaban Production and Market Share by Regions (2011-2016) 25
3.2 Global Rivaroxaban (Value) and Market Share by Regions (2011-2016) 26
3.3 Global Rivaroxaban Production, Revenue, Price and Gross Margin (2011-2016) 27
3.4 Europe Rivaroxaban Production, Revenue, Price and Gross Margin (2011-2016) 28
4 Global Rivaroxaban Supply (Production), Consumption, Export, Import by Regions (2011-2016) 29
4.1 Global Rivaroxaban Consumption by Regions (2011-2016) 29
4.2 North America Rivaroxaban Supply, Consumption, Export, Import by Regions (2011-2016) 31
4.3 Europe Rivaroxaban Supply, Consumption, Export, Import by Regions (2011-2016) 32
4.4 China Rivaroxaban Supply, Consumption, Export, Import by Regions (2011-2016) 32
4.5 Japan Rivaroxaban Supply, Consumption, Export, Import by Regions (2011-2016) 32
4.6 Southeast Asia Rivaroxaban Supply, Consumption, Export, Import by Regions (2011-2016) 33
4.7 India Rivaroxaban Supply, Consumption, Export, Import by Regions (2011-2016) 33
5 Global Rivaroxaban Production, Revenue (Value), Price Trend by Types 34
5.1 Global Rivaroxaban Production and Market Share by Types (2011-2016) 34
5.2 Global Rivaroxaban and Market Share by Types (2011-2016) 36
5.3 Global Rivaroxaban Price by Type (2011-2016) 38
5.4 Global Rivaroxaban Production Growth by Type (2011-2016) 38
6 Global Rivaroxaban Market Analysis by Applications 39
6.1 Global Rivaroxaban Consumption and Market Share by Applications (2011-2016) 39
6.2 Global Rivaroxaban Consumption Growth Rate by Applications (2011-2016) 40
7 Analysis of Rivaroxaban Industry Key Manufacturers 42
7.1 Bayer 42
7.1.1 Company Profile 42
7.1.2 Product Information 43
7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue 44
7.2 J&J 44
7.2.1 Company Profile 44
7.2.2 Product Information 46
7.2.3 Capacity, Production, Price, Cost, Gross, and Revenue 46
8 Rivaroxaban Manufacturing Cost Analysis 48
8.1 Rivaroxaban Key Raw Materials Analysis 48
8.1.1 Key Raw Materials 48
8.1.2 Key Suppliers of Raw Materials 48
8.2 Proportion of Manufacturing Cost Structure 49
8.2.1 Raw Materials 49
8.2.2 Labor Cost 49
8.2.3 Manufacturing Expenses 50
8.3 Manufacturing Process Analysis of Rivaroxaban 51
9 Industrial Chain, Sourcing Strategy and Downstream Buyers 52
9.1 Rivaroxaban Industrial Chain Analysis 52
9.2 Upstream Raw Materials Sourcing 52
9.3 Downstream Buyers 53
10 Marketing Strategy Analysis, Distributors/Traders 57
10.1 Marketing Channel 57
10.2 Market Positioning 57
10.3 Distributors/Traders List 59
11 Market Effect Factors Analysis 60
11.1 Consumer Needs/Customer Preference Change 61
11.2 Economic/Political Environmental Change 70
12 Global Rivaroxaban Market Forecast (2016-2021) 77
12.1 Global Rivaroxaban Production, Revenue Forecast (2016-2021) 77
12.2 Global Rivaroxaban Production, Consumption Forecast by Regions (2016-2021) 78
12.3 Global Rivaroxaban Revenue Forecast by Type (2016-2021) 79
12.4 Global Rivaroxaban Consumption Forecast by Application (2016-2021) 80
13 Research Findings and Conclusion 81
14 Appendix 83
Author List 83
Disclosure Section 83
Research Methodology 84
Data Source 86
China Disclaimer 86
List of Tables and Figures
Figure Picture of Rivaroxaban 1
Table Characteristics of Rivaroxaban 2
Figure Global Production Market Share of Rivaroxaban by Types in 2015 3
Table Classification of Rivaroxaban by Dose 3
Figure Product Picture of 2.5 mg 4
Table Characteristics of 2.5 mg 4
Figure Product Picture of 10 mg 5
Table Characteristics of 10 mg 5
Figure Product Picture of 15 mg 6
Table Characteristics of 15 mg 7
Figure Product Picture of 20 mg 8
Table Characteristics of 20 mg 8
Figure Rivaroxaban Consumption Market Share by Applications in 2015 10
Figure North America Rivaroxaban Market Size (Million USD) and Growth Rate (2011-2021) 11
Figure China Rivaroxaban Market Size (Million USD) and Growth Rate (2011-2021) 12
Figure Europe Rivaroxaban Market Size (Million USD) and Growth Rate (2011-2021) 12
Figure Japan Rivaroxaban Market Size (Million USD) and Growth Rate (2011-2021) 13
Figure Southeast Asia Rivaroxaban Market Size (Million USD) and Growth Rate (2011-2021) 14
Figure India Rivaroxaban Market Size (Million USD) and Growth Rate (2011-2021) 15
Figure Global Rivaroxaban Revenue (Million USD) and Growth Rate (2011-2021) 16
Table Global Rivaroxaban Sales (M Units) of Key Manufacturers (2015 and 2016) 17
Table Global Rivaroxaban Production Share by Manufacturers (2015 and 2016) 17
Figure 2015 Rivaroxaban Sales Share by Manufacturers 18
Figure 2016 Rivaroxaban Sales Share by Manufacturers 18
Table Global Rivaroxaban Revenue (Million USD) by Manufacturers (2015 and 2016) 19
Table Global Rivaroxaban Revenue Share by Manufacturers (2015 and 2016) 19
Figure 2015 Global Rivaroxaban Revenue Share by Manufacturers 20
Figure 2016 Global Rivaroxaban Revenue Share by Manufacturers 20
Table Global Market Rivaroxaban Average Price (USD/Unit) of Key Manufacturers (2015 and 2016) 21
Figure Global Market Rivaroxaban Average Price (USD/Unit) of Key Manufacturers in 2015 21
Table Manufacturers Rivaroxaban Manufacturing Base Distribution and Sales Area 22
Table Manufacturers Rivaroxaban Product 22
Figure 2015 Global Rivaroxaban Revenue Share by Manufacturers 23
Table Global Rivaroxaban Production (M Units) by Regions (2011-2016) 25
Figure Global Rivaroxaban Production and Market Share by Regions (2011-2016) 25
Figure 2015 Global Rivaroxaban Production Market Share by Regions 26
Table Global Rivaroxaban Revenue (Million USD) by Regions (2011-2016) 26
Table Global Rivaroxaban Market Size Market Share by Regions (2011-2016) 26
Table 2015 Global Rivaroxaban Market Size Market Share by Regions 27
Table Global Rivaroxaban Production, Revenue, Price and Gross Margin (2011-2016) 27
Table Europe Rivaroxaban Production, Revenue, Price and Gross Margin (2011-2016) 28
Table Global Rivaroxaban Consumption (M USD) Market by Regions (2011-2016) 29
Table Global Rivaroxaban Consumption Market Share by Regions (2011-2016) 29
Figure Global Rivaroxaban Consumption Market Share by Regions (2011-2016) 30
Figure 2015 Global Rivaroxaban Consumption Market Share by Regions 31
Table North America Rivaroxaban Supply, Consumption, Import & Export (2011-2016) 31
Table Europe Rivaroxaban Supply, Consumption, Import & Export (2011-2016) 32
Table China Rivaroxaban Supply, Consumption, Import & Export (2011-2016) 32
Table Japan Rivaroxaban Supply, Consumption, Import & Export (2011-2016) 32
Table Southeast Asia Rivaroxaban Supply, Consumption, Import & Export (2011-2016) 33
Table India Rivaroxaban Supply, Consumption, Import & Export (2011-2016) 33
Table Global Rivaroxaban Production (M Units) by Types (2011-2016) 34
Table Global Rivaroxaban Production Share by Types (2011-2016) 34
Figure Production Market Share of Rivaroxaban by Types (2011-2016) 35
Figure 2015 Production Market Share of Rivaroxaban by Types 35
Table Global Rivaroxaban Revenue (M USD) by Types (2011-2016) 36
Table Global Rivaroxaban Revenue Share by Types (2011-2016) 36
Figure Revenue Share of Rivaroxaban by Types (2011-2016) 37
Figure 2015 Market Size Market Share of Rivaroxaban by Types 37
Table Global Rivaroxaban Price (USD/Unit) by Types (2011-2016) 38
Figure Global Rivaroxaban Production Growth by Type (2011-2016) 38
Table Global Rivaroxaban Consumption (M USD) by Applications (2011-2016) 39
Table Global Rivaroxaban Consumption Market Share by Applications (2011-2016) 39
Figure Global Rivaroxaban Consumption Market Share by Applications in 2015 40
Table Global Rivaroxaban Consumption Growth Rate by Applications (2011-2016) 40
Figure Global Rivaroxaban Consumption Growth Rate by Applications (2011-2016) 41
Table Bayer Company Profile 42
Figure Rivaroxaban Product Picture and Specifications of Bayer 43
Table Rivaroxaban Sales (M Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Bayer 2015-2016 44
Table J&J Company Profile 44
Figure Rivaroxaban Product Picture and Specifications of J&J 46
Table Rivaroxaban Sales (M Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of J&J 2015-2016 46
Table List of Excipients of Rivaroxaban 48
Figure Manufacturing Cost Structure of Rivaroxaban 49
Figure 2015 EMEA Overview of Average Monthly Labor Cost 50
Figure Manufacturing Process Analysis of Rivaroxaban 51
Figure Rivaroxaban Industrial Chain Analysis 52
Table Major Buyers of Rivaroxaban 53
Figure Marketing Channels of Rivaroxaban 57
Table Distributors/Traders List 59
Figure Out-of-pocket Expenditure on Health as a Percentage of Total Expenditure on Health (%) in 2014 61
Figure Total Expenditure on Health as a Percentage of GDP (%) in 2014 62
Figure Global Average Health Expenditure, Total (% of GDP) 63
Table USA Health Expenditure Ratios from 1995-2014 63
Table China Health Expenditure Ratios from 1995-2014 64
Table Japan Health Expenditure Ratios from 1995-2014 65
Table Germany Health Expenditure Ratios from 1995-2014 66
Table UK Health Expenditure Ratios from 1995-2014 67
Table India Health Expenditure Ratios from 1995-2014 68
Table Canada Health Expenditure Ratios from 1995-2014 69
Figure Global GDP Map 2014 71
Figure EU GDP Change 2005-2014 71
Figure German CPI Change 2011-2015 72
Figure UK CPI Change 2011-2015 72
Figure Japan GDP Change 2005-2014 73
Figure Japan CPI Change 2005-2014 73
Figure China GDP Change 2005-2014 74
Figure China CPI Change 2005-2014 74
Figure China PPI Growth Rate 2005-2014 75
Figure US GDP Change 2005-2014 75
Figure US CPI Change 2011-2015 76
Figure Global Rivaroxaban Production and Growth Rate Forecast (2016-2021) 77
Figure Global Rivaroxaban Revenue (M USD) and Growth Rate Forecast (2016-2021) 78
Table Global Rivaroxaban Production (M Units) Forecast by Regions (2016-2021) 78
Table Global Rivaroxaban Consumption (M USD) Forecast by Regions (2016-2021) 78
Table Global Rivaroxaban Revenue (M USD) Forecast by Type (2016-2021) 79
Table Global Rivaroxaban Consumption (M USD) Forecast by Application (2016-2021) 80
  • Global Thin Film Drug Market Research Report 2017
    Published: 13-Dec-2017        Price: US 2900 Onwards        Pages: 118
    In this report, the global Thin Film Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Thin Film Drug in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan......
  • United States Inhalation & Nasal Spray Generic Drugs Market Report 2017
    Published: 12-Dec-2017        Price: US 3800 Onwards        Pages: 110
    In this report, the United States Inhalation & Nasal Spray Generic Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market sh......
  • North America Thin Film Drug Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 12-Dec-2017        Price: US 4480 Onwards        Pages: 121
    Thin-film drug delivery uses a dissolving film or oral drug strip to administer drugs via absorption in the mouth and/or via the small intestines. A film is prepared using hydrophilic polymers that rapidly dissolves on the tongue or buccal cavity, delivering the drug to the systemic circulation via dissolution when contact with liquid is made. Scope of the Report: This report focuses on the Thin Film Drug in North America market, especially in United States, Canada and Mexi......
  • Global Human Combination Vaccines Sales Market Report 2017
    Published: 12-Dec-2017        Price: US 4000 Onwards        Pages: 104
    In this report, the global Human Combination Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Human Combination Vaccines for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe......
  • Global Varicella Attenuated Live Vaccine Market Research Report 2017
    Published: 12-Dec-2017        Price: US 2900 Onwards        Pages: 109
    In this report, the global Varicella Attenuated Live Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Varicella Attenuated Live Vaccine in these regions, from 2012 to 2022 (forecast), covering - North America ......
  • Global Omnitrope Sales Market Report 2017
    Published: 12-Dec-2017        Price: US 4000 Onwards        Pages: 108
    In this report, the global Omnitrope market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Omnitrope for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan - Southeast......
  • United States Bioengineered Protein Drugs Market Report 2017
    Published: 12-Dec-2017        Price: US 3800 Onwards        Pages: 112
    In this report, the United States Bioengineered Protein Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and gro......
  • United States Fosfomycin Trometamol Market Report 2017
    Published: 12-Dec-2017        Price: US 3800 Onwards        Pages: 104
    In this report, the United States Fosfomycin Trometamol market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth ra......
  • Global Nasal Drops Market Research Report 2017
    Published: 12-Dec-2017        Price: US 2900 Onwards        Pages: 117
    In this report, the global Nasal Drops market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Nasal Drops in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs